These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 30755511)

  • 1.
    Applen Clancey S; Ciccone EJ; Coelho MA; Davis J; Ding L; Betancourt R; Glaubiger S; Lee Y; Holland SM; Gilligan P; Sung J; Heitman J
    mBio; 2019 Feb; 10(1):. PubMed ID: 30755511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients.
    Saijo T; Chen J; Chen SC; Rosen LB; Yi J; Sorrell TC; Bennett JE; Holland SM; Browne SK; Kwon-Chung KJ
    mBio; 2014 Mar; 5(2):e00912-14. PubMed ID: 24643864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular evidence that the range of the Vancouver Island outbreak of Cryptococcus gattii infection has expanded into the Pacific Northwest in the United States.
    Byrnes EJ; Bildfell RJ; Frank SA; Mitchell TG; Marr KA; Heitman J
    J Infect Dis; 2009 Apr; 199(7):1081-6. PubMed ID: 19220140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly recombinant VGII Cryptococcus gattii population develops clonal outbreak clusters through both sexual macroevolution and asexual microevolution.
    Billmyre RB; Croll D; Li W; Mieczkowski P; Carter DA; Cuomo CA; Kronstad JW; Heitman J
    mBio; 2014 Jul; 5(4):e01494-14. PubMed ID: 25073643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryptococcus gattii in the United States: genotypic diversity of human and veterinary isolates.
    Lockhart SR; Iqbal N; Harris JR; Grossman NT; DeBess E; Wohrle R; Marsden-Haug N; Vugia DJ
    PLoS One; 2013; 8(9):e74737. PubMed ID: 24019979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryptococcus gattii in North American Pacific Northwest: whole-population genome analysis provides insights into species evolution and dispersal.
    Engelthaler DM; Hicks ND; Gillece JD; Roe CC; Schupp JM; Driebe EM; Gilgado F; Carriconde F; Trilles L; Firacative C; Ngamskulrungroj P; Castañeda E; Lazera Mdos S; Melhem MS; Pérez-Bercoff A; Huttley G; Sorrell TC; Voelz K; May RC; Fisher MC; Thompson GR; Lockhart SR; Keim P; Meyer W
    mBio; 2014 Jul; 5(4):e01464-14. PubMed ID: 25028429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-GM-CSF autoantibodies predict outcome of cryptococcal meningitis in patients not infected with HIV: A cohort study.
    Jiang YK; Zhou LH; Cheng JH; Zhu JH; Luo Y; Li L; Zhu M; Zhu RS; Qiu WJ; Zhao HZ; Wang X; Huang JT; Cornely OA; Zhang WH; Zhu LP
    Clin Microbiol Infect; 2024 May; 30(5):660-665. PubMed ID: 38295989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging Cryptococcus gattii species complex infections in Guangxi, southern China.
    Huang C; Tsui CKM; Chen M; Pan K; Li X; Wang L; Chen M; Zheng Y; Zheng D; Chen X; Jiang L; Wei L; Liao W; Cao C
    PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008493. PubMed ID: 32845884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of Cryptococcus gattii-- Pacific Northwest, 2004-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Jul; 59(28):865-8. PubMed ID: 20651641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies Neutralizing GM-CSF in HIV-Negative Colombian Patients Infected with Cryptococcus gattii and C. neoformans.
    Arango-Franco CA; Rojas J; Firacative C; Migaud M; Agudelo CI; Franco JL; Casanova JL; Puel A; Lizarazo J; Castañeda E; Arias AA
    J Clin Immunol; 2024 Jul; 44(7):163. PubMed ID: 39008214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disseminated Cryptococcosis Due to Anti-Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies in the Absence of Pulmonary Alveolar Proteinosis.
    Kuo CY; Wang SY; Shih HP; Tu KH; Huang WC; Ding JY; Lin CH; Yeh CF; Ho MW; Chang SC; He CY; Chen HK; Ho CH; Lee CH; Chi CY; Ku CL
    J Clin Immunol; 2017 Feb; 37(2):143-152. PubMed ID: 28013480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryptococcus gattii Species Complex as an Opportunistic Pathogen: Underlying Medical Conditions Associated with the Infection.
    Yang DH; England MR; Salvator H; Anjum S; Park YD; Marr KA; Chu LA; Govender NP; Lockhart SR; Desnos-Ollivier M; Chen S; Halliday C; Kan A; Chen J; Wollenberg KR; Zelazny A; Perfect JR; Chang YC; Bennett JE; Holland SM; Meyer W; Williamson PR; Kwon-Chung KJ
    mBio; 2021 Oct; 12(5):e0270821. PubMed ID: 34700378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryptococcus gattii in the United States: clinical aspects of infection with an emerging pathogen.
    Harris JR; Lockhart SR; Debess E; Marsden-Haug N; Goldoft M; Wohrle R; Lee S; Smelser C; Park B; Chiller T
    Clin Infect Dis; 2011 Dec; 53(12):1188-95. PubMed ID: 22016503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-GM-CSF Neutralizing Autoantibodies in Colombian Patients with Disseminated Cryptococcosis.
    Arango-Franco CA; Migaud M; Ramírez-Sánchez IC; Arango-Bustamante K; Moncada-Vélez M; Rojas J; Gervais A; Patiño-Giraldo S; Perez-Zapata LJ; Álvarez Álvarez JA; Orrego JC; Roncancio-Villamil G; Boisson-Dupuis S; Jouanguy E; Abel L; Casanova JL; Bustamante J; Arias AA; Franco JL; Puel A
    J Clin Immunol; 2023 Jul; 43(5):921-932. PubMed ID: 36821021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What makes Cryptococcus gattii a pathogen?
    Bielska E; May RC
    FEMS Yeast Res; 2016 Feb; 16(1):fov106. PubMed ID: 26614308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryptococcus gattii genotype VGIIa infection imported from Vancouver Island to Japan.
    Kitaura T; Takahashi M; Umeyama T; Takeshita N; Katanami Y; Takaya S; Yamamoto K; Kutsuna S; Hayakawa K; Kato Y; Yamauchi T; Narita Y; Miyazaki Y; Ohmagari N
    J Infect Chemother; 2018 Jul; 24(7):573-575. PubMed ID: 29352650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryptococcus gattii Infection as the Major Clinical Manifestation in Patients with Autoantibodies Against Granulocyte-Macrophage Colony-Stimulating Factor.
    Wang SY; Lo YF; Shih HP; Ho MW; Yeh CF; Peng JJ; Ting HT; Lin KH; Huang WC; Chen YC; Chiu YH; Hsu CW; Tseng YT; Wang LS; Lei WY; Lin CY; Aoh Y; Chou CH; Wu TY; Ding JY; Lo CC; Lin YN; Tu KH; Lei WT; Kuo CY; Chi CY; Ku CL
    J Clin Immunol; 2022 Nov; 42(8):1730-1741. PubMed ID: 35947322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First reported case of Cryptococcus gattii in the Southeastern USA: implications for travel-associated acquisition of an emerging pathogen.
    Byrnes EJ; Li W; Lewit Y; Perfect JR; Carter DA; Cox GM; Heitman J
    PLoS One; 2009 Jun; 4(6):e5851. PubMed ID: 19516904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disseminated cryptococcosis and anti-granulocyte-macrophage colony-stimulating factor autoantibodies: An underappreciated association.
    Viola GM; Malek AE; Rosen LB; DiNardo AR; Nishiguchi T; Okhuysen PC; Holland SM; Kontoyiannis DP
    Mycoses; 2021 Jun; 64(6):576-582. PubMed ID: 33476401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryptococcus gattii infections in multiple states outside the US Pacific Northwest.
    Harris JR; Lockhart SR; Sondermeyer G; Vugia DJ; Crist MB; D'Angelo MT; Sellers B; Franco-Paredes C; Makvandi M; Smelser C; Greene J; Stanek D; Signs K; Nett RJ; Chiller T; Park BJ
    Emerg Infect Dis; 2013 Oct; 19(10):1620-6. PubMed ID: 24050410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.